Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.
CHARLOTTE, NC (PR NEWSWIRE) APRIL 05, 2018 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the enrollment of over 100 patients from the United States into the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry.
Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017
CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to announce an increase in Medicare payment for prostate HIFU ablation in the Ambulatory Surgical Center (ASC) setting.
CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility between bkFusion and Sonablate® planning software for the ablation of prostate tissue.
Read more: SONACARE MEDICAL DELIVERS COMPATIBILITY WITH BKFUSION
Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the imminent reimbursement for HIFU prostate tissue ablation with a newly approved C-code.
Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU Registry. The High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry will be a globally accessible, web-based, platform for storing HIFU data on patients treated with Sonablate.
Read more: International Sonablate HIFU Prostate Registry Officially Launched
Charlotte, NC (PR Newswire) January 11th, 2017 - SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, reports receipt of 510(k) regulatory clearance to market its latest version of Sonablate® in the United States. Sonablate was the first HIFU device to receive regulatory authorization from the Food and Drug Administration (FDA) for the focused ablation of prostate tissue.
Charlotte, NC (PR Newswire) Oct 5th, 2016, SonaCare Medical, leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, reports over 40 acquisitions of Sonablate® technology since the device received FDA clearance on October 09, 2015.
Charlotte, NC (PR Newswire) May 5th, 2016, SonaCare Medical, the leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, announces today a marketing alliance with Invivo, a business of Royal Philips (NYSE: PHG; AEX: PHIA) with over 20-years of history as the pioneer of progressive MRI coils, advanced clinical visualization systems, and MRI-compatible interventional devices.
“A fast and accurate fusion is the key to being able to use disease-based information from a diagnostic MRI to drive a focused ultrasound ablation”
CHARLOTTE, N.C., APRIL 26, 2016 – SonaCare Medical, the leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, announces today the execution of a groundbreaking licensing agreement with MIM®, a world leader in the development and deployment of medical imaging and analysis software applications.
address 10130 Perimeter Pkwy, Suite 410
Charlotte, NC 28216
phone (888) 874-4384
email info@SonaCareMedical.com
workhour Mon - Fri: 9:00 - 5:00
